ETHNOPHARMACOLOGICAL RELEVANCE: Large-scale study of @entity1058 ( @entity1058 ) usage among @entity1 with @entity309 ( @entity309 ) is lacking. The aim of this study is to evaluate the @entity1058 usage among @entity309 @entity1 in Taiwan. MATERIALS AND METHODS: We examined the "registry for @entity16839 @entity1 dataset" of the National Health Insurance Research Database (NHIRD; n=23 million @entity1 ) in Taiwan. @entity1 (n=25,263) newly diagnosed as @entity309 in 2001-2009 were included and then followed-up until the end of 2011. Based on the medical utilization, they were further categorized into @entity1058 users (n=6,891; 27.3%) and non- @entity1058 users (n=18,372; 72.7%). The demographic data and core prescription patterns of the @entity1058 users were analyzed. RESULTS: Compared to non- @entity1058 user, @entity1058 users were younger (mean age: 49.6 versus 54.0 years), had a higher female/male ratio (82.7%/17.3% versus 74.1%/25.9%), resided in more urbanized area. Herbal remedies were the most commonly used therapeutic approach (76.4%), followed by combining acupuncture (21.1%). The frequency of outpatient visits in @entity1058 users was higher across all disease categories except circulatory system. The most commonly prescribed formula and herb was Shang-Jong-Shiah-Tong-Yong-Tong-Feng-Wan and Rhizoma Corydalis, respectively. The analysis of core pattern revealed that Dang-Gui-Nian-Tong-Tang, Shu-Jing-Huo-Xie-Tang, Gui-Zhi-Shao-Yao-Zhi-Mu-Tang, Myrrha and Olibanum, were among the most frequently used combinations. @entity309 @entity1 who had @entity148 and @entity308 , @entity2023 , @entity170 , @entity1866 , and @entity7793 were prone to have more @entity1058 visits compared to non- @entity1058 users. CONCLUSIONS: Our population-based study revealed the high prevalence and specific usage patterns of @entity1058 in the @entity309 @entity1 in Taiwan. The information could be used for further pharmacological investigation and clinical trials.

Characteristics of Traditional Chinese Medicine Use in @entity1 with XXXX in Taiwan: A Nationwide Population-Based Study.

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients', 'patient', 'people'] @entity308 :: ('MESH:D003866', 'Disease') :: ['depression'] @entity2023 :: ('MESH:D006255', 'Disease') :: ['allergic rhinitis'] @entity170 :: ('MESH:D010024', 'Disease') :: ['osteoporosis'] @entity7793 :: ('MESH:D008594', 'Disease') :: ['menopausal syndrome'] @entity1866 :: ('MESH:D008599', 'Disease') :: ['menstrual disorder'] @entity16839 :: ('MESH:D002388', 'Disease') :: ['catastrophic illness'] @entity148 :: ('MESH:D001008', 'Disease') :: ['anxiety'] @entity1058 :: ('MESH:C562377', 'Disease') :: ['traditional Chinese medicine', 'TCM'] @entity309 :: ('MESH:D001172', 'Disease') :: ['rheumatoid arthritis', 'RA']
@entity309 :: (MESH:D001172,Disease) :: ['Rheumatoid Arthritis']
